North Carolina's residential opioid treatment services lack evidence-based approaches

A new study of organizations that claim to provide residential opioid substance use services in North Carolina found that only 12% of the organizations were licensed by the state to provide residential substance use treatment. What's more, only about a quarter of the organizations even allowed patients to access the only treatment for opioid use disorder proven to reduce overdose deaths.

We wanted to know how many organizations in North Carolina that purport to provide residential opioid substance use services actually provide patients with evidence-based treatment or allow patients to access evidence-based treatment services. Specifically, we wanted to know how many of these organizations allowed patients to access opioid agonist treatment (OAT)."

Jennifer Carroll, Study Lead Author and Associate Professor, Anthropology, North Carolina State University

OAT refers to treatment services that use FDA-approved opioid medications, such as methadone or buprenorphine, to treat addiction and help patients cease illicit substance use.

"We focused on OAT because OAT programs have better outcomes than other treatments by virtually every measure – and have also been proven to cut the risk of overdose deaths in half," Carroll says.

For the study, researchers conducted a statewide inventory of residential substance use service providers in North Carolina. The researchers then had "secret shoppers" pose as people seeking help for heroin addiction and call every organization that claimed to provide residential services for opioid use disorder, with the goal of learning more about what services the different programs offered. The researchers identified 82 providers. Sixteen of the providers declined to answer any questions when contacted. The remaining 66 answered some or all of the questions from the researchers.

The study found that only seven of the organizations provided OAT to patients on site, while an additional nine organizations allowed patients to access OAT through an outside or community-based prescriber. In addition, only eight of the providers were licensed to provide residential substance use treatment.

"Thousands of North Carolinians die of opioid overdoses every year," Carroll says. "And most of the places in North Carolina that people might turn to for help don't allow patients to access the treatment that is most likely to help them stay alive and treat their opioid use disorder.

"What's more, we found that 33 – fully half – of the organizations we talked with were dismissive of OAT services."

The researchers also found that 20 of the service providers fit a very specific profile: they were faith-based organizations that were not licensed to provide any form of substance use-related services, barred access to OAT, and required patients to work without pay – often for businesses that were owned and operated by the organization itself.

"The fact that the most common residential substance use service providers in the state are not licensed in any way, do not allow patients to access OAT, and frequently profit from the unpaid labor of the patients they serve is deeply troubling," says Carroll.

"These findings suggest that public health would benefit from a rigorous assessment of the substance use treatment services being provided in North Carolina and the regulations that govern those services."

Source:
Journal references:

Carroll, J. K., et al. (2024) Evidence-based treatment for opioid use disorder is widely unavailable and often discouraged by providers of residential substance use services in North Carolina Journal of Substance Use and Addiction Treatment. doi.org/10.1016/j.josat.2024.209474

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration